{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T16:50:47Z","timestamp":1758473447196},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,4,9]],"date-time":"2016-04-09T00:00:00Z","timestamp":1460160000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s10620-016-4146-x","type":"journal-article","created":{"date-parts":[[2016,4,9]],"date-time":"2016-04-09T05:14:37Z","timestamp":1460178877000},"page":"2205-2216","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Preventative Care in the Patient with Inflammatory Bowel Disease: What Is New?"],"prefix":"10.1007","volume":"61","author":[{"given":"Jason S.","family":"Reich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis A.","family":"Farraye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharmeel K.","family":"Wasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,9]]},"reference":[{"key":"4146_CR1","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ibd.20266","volume":"14","author":"L Selby","year":"2008","unstructured":"Selby L, Kane S, Wilson J, et al. Receipt of preventive health services by IBD patients is significantly lower than by primary care patients. Inflamm Bowel Dis. 2008;14:253\u2013258.","journal-title":"Inflamm Bowel Dis"},{"key":"4146_CR2","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s10620-010-1329-8","volume":"56","author":"L Selby","year":"2011","unstructured":"Selby L, Hoellein A, Wilson JF. Are primary care providers uncomfortable providing routine preventive care of inflammatory bowel disease patients. Dig Dis Sci. 2011;56:819\u2013824. doi: 10.1007\/s10620-010-1329-8 .","journal-title":"Dig Dis Sci"},{"key":"4146_CR3","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/ajg.2009.733","volume":"105","author":"SK Wasan","year":"2010","unstructured":"Wasan SK, Baker SE, Skolnik PR, Farraye FA. A practical guide to vaccinating the inflammatory bowel disease patient. Am J Gastroenterol. 2010;105:1231\u20131238. doi: 10.1038\/ajg.2009.733 .","journal-title":"Am J Gastroenterol"},{"key":"4146_CR4","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/gut.2004.040675","volume":"53","author":"M Esteve","year":"2004","unstructured":"Esteve M, Saro C, Gonz\u00e1lez-huix F, Suarez F, Forn\u00e9 M, Viver JM. Chronic hepatitis B reactivation following infliximab therapy in Crohn\u2019s disease patients: need for primary prophylaxis. Gut. 2004;53:1363\u20131365.","journal-title":"Gut"},{"key":"4146_CR5","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1111\/j.1478-3231.2007.01665.x","volume":"28","author":"PM Montiel","year":"2008","unstructured":"Montiel PM, Solis JA, Chirinos JA, Acasis B, S\u00e1nchez F, Rodr\u00edguez S. Hepatitis B virus reactivation during therapy with etanercept in an HBsAg-negative and anti-HBs-positive patient. Liver Int. 2008;28:718\u2013720. doi: 10.1111\/j.1478-3231.2007.01665.x .","journal-title":"Liver Int"},{"key":"4146_CR6","first-page":"1","volume":"53","author":"SA Harper","year":"2004","unstructured":"Harper SA, Fukuda K, Uyeki TM, Cox NJ, Bridges CB. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2004;53:1\u201340.","journal-title":"MMWR Recomm Rep"},{"key":"4146_CR7","first-page":"556","volume":"48","author":"CDC","year":"1999","unstructured":"CDC. Reason reported by Medicare beneficiaries for not receiving influenza and pneumococcal vaccinations\u2014United States 1996. MMWR. 1999;48:556\u2013980.","journal-title":"MMWR"},{"key":"4146_CR8","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1093\/ecco-jcc\/jjv064","volume":"6","author":"G Malhi","year":"2015","unstructured":"Malhi G, Rumman A, Thanabalan R, et al. Vaccination in inflammatory bowel disease patients: attitudes, knowledge, and uptake. J Crohn\u2019s Colitis. 2015;6:439\u2013444. doi: 10.1093\/ecco-jcc\/jjv064 .","journal-title":"J Crohn\u2019s Colitis"},{"key":"4146_CR9","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1002\/ibd.21667","volume":"12","author":"SK Wasan","year":"2011","unstructured":"Wasan SK, Coukos JA, Farraye FA. Vaccinating the inflammatory bowel disease patient: deficiencies in gastroenterologists knowledge. Inflamm Bowel Dis. 2011;12:2536\u20132540. doi: 10.1002\/ibd.21667 .","journal-title":"Inflamm Bowel Dis"},{"key":"4146_CR10","first-page":"A-51","volume":"132","author":"I Dotan","year":"2007","unstructured":"Dotan I, Vigodman S, Malter L, et al. Azathioprine\/6-mercaptopurine therapy has no significant effect on cellular or humoral immune responses in patients with inflammatory bowel disease. Gastroenterology. 2007;132:A-51.","journal-title":"Gastroenterology"},{"key":"4146_CR11","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/ajg.2009.523","volume":"105","author":"GY Melmed","year":"2010","unstructured":"Melmed GY, Agarwal N, Frenck RW, et al. Immunosuppression impairs response to pneumococcal polysaccharide vaccination in patients with inflammatory bowel disease. Am J Gastroenterol. 2010;105:148\u2013154. doi: 10.1038\/ajg.2009.523 .","journal-title":"Am J Gastroenterol"},{"key":"4146_CR12","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/00054725-200409000-00028","volume":"10","author":"BE Sands","year":"2004","unstructured":"Sands BE, Cuffari C, et al. Guidelines for immunizations in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2004;10:677\u2013692.","journal-title":"Inflamm Bowel Dis"},{"key":"4146_CR13","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1136\/gut.2010.233981","volume":"60","author":"JF Rahier","year":"2011","unstructured":"Rahier JF, Papay P, Salleron J, et al. H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biological therapy. Gut. 2011;60:456\u2013462. doi: 10.1136\/gut.2010.233981 .","journal-title":"Gut"},{"key":"4146_CR14","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/ibd.21688","volume":"18","author":"I Dotan","year":"2012","unstructured":"Dotan I, Werner L, Vigodman S, et al. Normal response to vaccines in inflammatory bowel disease patients treated with thiopurines. Inflamm Bowel Dis. 2012;18:261\u2013268. doi: 10.1002\/ibd.21688 .","journal-title":"Inflamm Bowel Dis"},{"key":"4146_CR15","first-page":"1","volume":"47","author":"JC Watson","year":"1998","unstructured":"Watson JC, Hadler SC, Dykewicz CA, Reef S, Phillips L. Measles, mumps, and rubella\u2014vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 1998;47:1\u201357.","journal-title":"MMWR"},{"key":"4146_CR16","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/ijcp.12508","volume":"69","author":"SY Tsai","year":"2015","unstructured":"Tsai SY, Yang TY, Lin CL, Tsai YH, Kuo CF, Kao CH. Increased risk of varicella zoster virus infection in inflammatory bowel disease in an Asian population: a nationwide population-based cohort study. Int J Clin Pract. 2015;69:228\u2013234. doi: 10.1111\/ijcp.12508 .","journal-title":"Int J Clin Pract"},{"key":"4146_CR17","first-page":"56","volume":"1","author":"M Ham","year":"2013","unstructured":"Ham M, Cullen G, Cheifetz AS. Varicella zoster virus infection in patients with inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2013;1:56\u201358.","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"4146_CR18","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/ibd.20161","volume":"13","author":"CN Kotton","year":"2007","unstructured":"Kotton CN. Nailing down the shingles in IBD. Inflamm Bowel Dis. 2007;13:1178\u20131179.","journal-title":"Inflamm Bowel Dis"},{"key":"4146_CR19","first-page":"1","volume":"56","author":"M Marin","year":"2007","unstructured":"Marin M, G\u00fcris D, Chaves SS, Schmid S, Seward JF. Prevention of varicella recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2007;56:1\u201340.","journal-title":"MMWR"},{"key":"4146_CR20","doi-asserted-by":"publisher","first-page":"e004833","DOI":"10.1136\/bmjopen-2014-004833","volume":"4","author":"K Kawai","year":"2014","unstructured":"Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open. 2014;4:e004833. doi: 10.1136\/bmjopen-2014-004833 .","journal-title":"BMJ Open"},{"key":"4146_CR21","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.cgh.2006.09.019","volume":"4","author":"G Gupta","year":"2006","unstructured":"Gupta G, Lautenbach E, Lewis JD. Incidence and risk factors for herpes zoster among patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2006;4:1483\u20131490.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4146_CR22","first-page":"1","volume":"57","author":"R Harpaz","year":"2008","unstructured":"Harpaz R, Ortega-Sanchez IR, Seward JF, Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Prevention of herpes zoster recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2008;57:1\u201330.","journal-title":"MMWR"},{"key":"4146_CR23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1001\/jama.2012.7304","volume":"308","author":"J Zhang","year":"2012","unstructured":"Zhang J, Xie F, Delzell E, et al. Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases. JAMA. 2012;308:43\u201349. doi: 10.1001\/jama.2012.7304 .","journal-title":"JAMA"},{"key":"4146_CR24","doi-asserted-by":"crossref","unstructured":"Wasan, S., Zullow, S., Berg, A. Herpes zoster vaccine response in inflammatory bowel disease patients on low dose immunosuppresion. Inflamm Bowel Dis. 2015 (in press).","DOI":"10.1097\/MIB.0000000000000743"},{"key":"4146_CR25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3949\/ccjm.75a.08046","volume":"76","author":"A Singh","year":"2009","unstructured":"Singh A, Englund K. Q: Who should receive the shingles vaccine? Cleve Clin J Med. 2009;76:45\u201348.","journal-title":"Cleve Clin J Med"},{"key":"4146_CR26","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.cgh.2007.02.035","volume":"5","author":"P Mamula","year":"2007","unstructured":"Mamula P, Markowitz JE, Piccoli DA, Klimov A, Cohen L, Baldassano RN. Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007;5:851\u2013856.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4146_CR27","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/ajg.2008.120","volume":"104","author":"Y Lu","year":"2009","unstructured":"Lu Y, Jacobson DL, Ashworth LA, et al. Immune response to influenza vaccine in children with inflammatory bowel disease. Am J Gastroenterol. 2009;104:444\u2013453. doi: 10.1038\/ajg.2008.120 .","journal-title":"Am J Gastroenterol"},{"key":"4146_CR28","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/ard.2007.077552","volume":"67","author":"LB Gelinck","year":"2008","unstructured":"Gelinck LB, van der Bijl AE, Beyer WE, et al. The effect of antitumour necrosis factor alpha treatment on the antibody response to influenza vaccination. Ann Rheum Dis. 2008;67:713\u2013716.","journal-title":"Ann Rheum Dis"},{"key":"4146_CR29","unstructured":"PCV13 (Pneumococcal Conjugate) Vaccine. CDC, 2014-9-29, cited 2015-6-1 http:\/\/www.cdc.gov\/vaccines\/vpd-vac\/pneumo\/vac-PCV13-adults.htm ."},{"key":"4146_CR30","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.crohns.2013.09.022","volume":"5","author":"CK Lee","year":"2014","unstructured":"Lee CK, Kim HS, Ye BD, et al. Patients with Crohn\u2019s disease on anti-tumor necrosis factor therapy are at significant risk of inadequate response to the 23-valent pneumococcal polysaccharide vaccine. J Crohns Colitis. 2014;5:384\u2013391. doi: 10.1016\/j.crohns.2013.09.022 .","journal-title":"J Crohns Colitis"},{"key":"4146_CR31","first-page":"69","volume":"24","author":"MD Brogan","year":"1987","unstructured":"Brogan MD, Shanahan F, Oliver M, Stevens RH, Targan SR. Defective memory B cell formation in patients with inflammatory bowel disease following tetanus toxoid booster immunization. J Clin Lab Immunol. 1987;24:69\u201374.","journal-title":"J Clin Lab Immunol"},{"key":"4146_CR32","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/003655201750074537","volume":"36","author":"HJ Nielsen","year":"2001","unstructured":"Nielsen HJ, Mortensen T, Holten-andersen M, Br\u00fcnner N, S\u00f8rensen S, Rask-madsen J. Increased levels of specific leukocyte- and platelet-derived substances during normal anti-tetanus antibody synthesis in patients with inactive Crohn disease. Scand J Gastroenterol. 2001;36:265\u2013269.","journal-title":"Scand J Gastroenterol"},{"key":"4146_CR33","first-page":"53","volume":"57","author":"Centers for Disease Control and Prevention","year":"2008","unstructured":"Centers for Disease Control and Prevention. Recommended adult immunization schedule\u2014United States, 2009. MMWR Recomm Rep. 2008;57:53.","journal-title":"MMWR Recomm Rep"},{"key":"4146_CR34","doi-asserted-by":"publisher","unstructured":"Rungoe C, Simonsen J, Riis L, Frisch M, Langholz E, Jess T. Inflammatory bowel disease and cervical neoplasia: a population-based nationwide cohort study. Clin Gastroenterol Hepatol. 2014. doi: 10.1016\/j.cgh.2014.07.036 .","DOI":"10.1016\/j.cgh.2014.07.036"},{"key":"4146_CR35","doi-asserted-by":"crossref","first-page":"40","DOI":"10.7326\/0003-4819-150-1-200901060-00008","volume":"150","author":"Advisory Committee on Immunization Practices","year":"2009","unstructured":"Advisory Committee on Immunization Practices. Recommended adult immunization schedule: United States, 2009*. Ann Intern Med. 2009;150:40\u201344.","journal-title":"Ann Intern Med"},{"key":"4146_CR36","first-page":"1705","volume":"60","author":"Centers for Disease Control and Prevention (CDC)","year":"2011","unstructured":"Centers for Disease Control and Prevention (CDC). Recommendations on the use of quadrivalent human papillomavirus vaccine in males\u2014Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. 2011;60:1705\u20131708.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"4146_CR37","doi-asserted-by":"publisher","first-page":"15358","DOI":"10.3748\/wjg.v20.i41.15358","volume":"20","author":"R Ben Musa","year":"2014","unstructured":"Ben Musa R, Gampa A, Basu S, et al. Hepatitis B vaccination in patients with inflammatory bowel disease. World J Gastroenterol. 2014;20:15358\u201315366. doi: 10.3748\/wjg.v20.i41.15358 .","journal-title":"World J Gastroenterol"},{"key":"4146_CR38","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1038\/ajg.2012.79","volume":"107","author":"JP Gisbert","year":"2012","unstructured":"Gisbert JP, Villagrasa JR, Rodriguez-Nogueiras A, Chaparro M. Efficacy of hepatitis B vaccination and revaccination and factors impacting response in patients with inflammatory bowel disease. Am J Gastroenterol. 2012;107:1460\u20131466. doi: 10.1038\/ajg.2012.79 .","journal-title":"Am J Gastroenterol"},{"key":"4146_CR39","doi-asserted-by":"crossref","unstructured":"Long, MD, Gulati, A, Wohl, D, Herfarth, H. Immunizations in pediatric and adult patients with inflammatory bowel disease: a practical case-based approach. Inflamm Bowel Dis. 2015","DOI":"10.1097\/MIB.0000000000000395"},{"key":"4146_CR40","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1086\/589722","volume":"198","author":"K Cardell","year":"2008","unstructured":"Cardell K, Akerlind B, Sallberg M, Fryden A. Excellent response rate to a double dose of the combined hepatitis A and B vaccine in previous nonresponders to hepatitis B vaccine. J Infect Dis. 2008;198:299\u2013304. doi: 10.1086\/589722 .","journal-title":"J Infect Dis"},{"key":"4146_CR41","first-page":"1","volume":"62","author":"CDC","year":"2013","unstructured":"CDC. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013;62:1\u201322.","journal-title":"MMWR Recomm Rep."},{"key":"4146_CR42","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1002\/ibd.22903","volume":"18","author":"D Soonawala","year":"2012","unstructured":"Soonawala D, van Eggermond A, Fidder H, Visser L. Pretravel preparation and travel-related morbidity in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2012;18:2079\u20132085.","journal-title":"Inflamm Bowel Dis"},{"key":"4146_CR43","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.cgh.2011.10.025","volume":"10","author":"S Ben-Horin","year":"2012","unstructured":"Ben-Horin S, Bujanover Y, Goldstein S, et al. Travel-associated health risks for patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2012;10:160\u2013165.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4146_CR44","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.crohns.2009.02.010","volume":"3","author":"JF Rahier","year":"2009","unstructured":"Rahier JF, Ben-Horin S, Chowers Y, et al. European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohn\u2019s Colitis. 2009;3:47\u201391.","journal-title":"J Crohn\u2019s Colitis"},{"key":"4146_CR45","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.3748\/wjg.v17.i22.2708","volume":"17","author":"M Esteve","year":"2011","unstructured":"Esteve M, Loras C, Garc\u00eda-Planella E. Inflammatory bowel disease in travelers: choosing the right vaccines and check-ups. World J Gastroenterol. 2011;17:2708\u20132714.","journal-title":"World J Gastroenterol"},{"key":"4146_CR46","doi-asserted-by":"crossref","first-page":"6266","DOI":"10.1016\/j.vaccine.2008.09.056","volume":"26","author":"AR Zanetti","year":"2008","unstructured":"Zanetti AR, Van Damme P, Shouval D. The global impact of vaccination against hepatitis B: a historical overview. Vaccine. 2008;26:6266\u20136273.","journal-title":"Vaccine"},{"key":"4146_CR47","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4161\/hv.4.2.5122","volume":"4","author":"AL Lopez","year":"2008","unstructured":"Lopez AL, Clemens JD, Deen J, Jodar L. Cholera vaccines for the developing world. Hum Vaccin. 2008;4:165\u2013169.","journal-title":"Hum Vaccin"},{"key":"4146_CR48","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1708-8305.2009.00330.x","volume":"16","author":"GD Burchard","year":"2009","unstructured":"Burchard GD, Caumes E, Connor BA, et al. Expert opinion on vaccination of travelers against Japanese encephalitis. J Travel Med. 2009;16:204\u2013216.","journal-title":"J Travel Med"},{"key":"4146_CR49","unstructured":"Dutch national guidelines on travel medicine. LCR Committee, 2010: 1\u2013544"},{"key":"4146_CR50","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1159\/000363228","volume":"90","author":"H Roberts","year":"2014","unstructured":"Roberts H, Rai SN, Pan J, et al. Extraintestinal manifestations of inflammatory bowel disease and the influence of smoking. Digestion. 2014;90:122. doi: 10.1159\/000363228 .","journal-title":"Digestion"},{"key":"4146_CR51","doi-asserted-by":"publisher","first-page":"12269","DOI":"10.3748\/wjg.v20.i34.12269","volume":"20","author":"C Ott","year":"2014","unstructured":"Ott C, Takses A, Obermeier F, Schnoy E, M\u00fcller M. Smoking increases the risk of extraintestinal manifestations in Crohn\u2019s disease. World J Gastroenterol. 2014;20:12269\u201312276. doi: 10.3748\/wjg.v20.i34.12269 .","journal-title":"World J Gastroenterol"},{"key":"4146_CR52","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1002\/ibd.20555","volume":"14","author":"J Cosnes","year":"2008","unstructured":"Cosnes J. What is the link between the use of tobacco and IBD? Inflamm Bowel Dis. 2008;14:S14\u2013S15. doi: 10.1002\/ibd.20555 .","journal-title":"Inflamm Bowel Dis"},{"key":"4146_CR53","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/00042737-199810000-00001","volume":"10","author":"DP Franchimont","year":"1998","unstructured":"Franchimont DP, Louis E, Croes F, Belaiche J. Clinical pattern of corticosteroid dependent Crohn\u2019s disease. Eur J Gastroenterol Hepatol. 1998;10:821\u2013825.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"4146_CR54","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1007\/s10620-012-2038-2","volume":"57","author":"Y Leung","year":"2012","unstructured":"Leung Y, Kaplan GG, Rioux KP, et al. Assessment of variables associated with smoking cessation in Crohn\u2019s disease. Dig Dis Sci. 2012;57:1026\u20131032. doi: 10.1007\/s10620-012-2038-2 .","journal-title":"Dig Dis Sci"},{"key":"4146_CR55","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1001\/jama.2013.284427","volume":"311","author":"PA James","year":"2014","unstructured":"James PA, Oparil S, Carter BL, et al. Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311:507\u2013520. doi: 10.1001\/jama.2013.284427 .","journal-title":"JAMA"},{"key":"4146_CR56","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1002\/ibd.20944","volume":"9","author":"M Moscandrew","year":"2009","unstructured":"Moscandrew M, Mahadevan U, Kane S. General health maintenance in IBD. Inflamm Bowel Dis. 2009;9:1399\u20131409. doi: 10.1002\/ibd.20944 .","journal-title":"Inflamm Bowel Dis"},{"key":"4146_CR57","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/ibd.22906","volume":"18","author":"C Hwang","year":"2012","unstructured":"Hwang C, Ross V, Mahadevan U. Micronutrient deficiencies in inflammatory bowel disease: from A to zinc. Inflamm Bowel Dis. 2012;18:1961\u20131981.","journal-title":"Inflamm Bowel Dis"},{"key":"4146_CR58","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(77)92127-4","volume":"1","author":"GL Hill","year":"1977","unstructured":"Hill GL, Blackett RL, Pickford I, et al. Malnutrition in surgical patients. An unrecognised problem. Lancet. 1977;1:689\u2013692.","journal-title":"Lancet"},{"key":"4146_CR59","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/MIB.0000000000000585","volume":"22","author":"J Limdi","year":"2016","unstructured":"Limdi J, Aggarwal D, McLaughlin J. Dietary practices and beliefs in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2016;22:164.","journal-title":"Inflamm Bowel Dis"},{"key":"4146_CR60","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.01.007","author":"D Lee","year":"2015","unstructured":"Lee D, Albenberg L, Compher C, et al. Diet in the pathogenesis and treatment of inflammatory bowel diseases. Gastroenterology. 2015;. doi: 10.1053\/j.gastro.2015.01.007 .","journal-title":"Gastroenterology"},{"key":"4146_CR61","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/00005176-200011000-00024","volume":"31","author":"R Heuschkel","year":"2000","unstructured":"Heuschkel R. Enteral nutrition in children with Crohn\u2019s disease. J Pediatr Gastroenterol Nutr. 2000;31:575.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"4146_CR62","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1586\/egh.11.29","volume":"5","author":"AC Brown","year":"2011","unstructured":"Brown AC, Rampertab SD, Mullin GE. Existing dietary guidelines for Crohn\u2019s disease and ulcerative colitis. Expert Rev Gastroenterol Hepatol. 2011;5:411\u2013425.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"4146_CR63","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1159\/000223695","volume":"16","author":"SF Ahmed","year":"2009","unstructured":"Ahmed SF, Elmantaser M. Secondary osteoporosis. Endocr Dev. 2009;16:170\u2013190. doi: 10.1159\/000223695 .","journal-title":"Endocr Dev"},{"key":"4146_CR64","doi-asserted-by":"publisher","first-page":"241","DOI":"10.4103\/1319-3767.98428","volume":"4","author":"KM Shirazi","year":"2012","unstructured":"Shirazi KM, Somi MH, Rezaeifar P, Fattahi I, Khoshbaten M, Ahmadzadeh M. Bone density and bone metabolism in patients with inflammatory bowel disease. Saudi J Gastroenterol. 2012;4:241\u2013247. doi: 10.4103\/1319-3767.98428 .","journal-title":"Saudi J Gastroenterol"},{"key":"4146_CR65","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/gut.40.3.313","volume":"40","author":"J Jahnsen","year":"1997","unstructured":"Jahnsen J, Falch JA, Aadland E, Mowinckel P. Bone mineral density is reduced in patients with Crohn\u2019s disease but not in patients ulcerative colitis: a population based study. Gut. 1997;40:313\u2013319.","journal-title":"Gut"},{"key":"4146_CR66","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1007\/s11894-014-0402-4","volume":"10","author":"CS Manolakis","year":"2014","unstructured":"Manolakis CS, Cash BD. Health maintenance and inflammatory bowel disease. Curr Gastroenterol Rep. 2014;10:402. doi: 10.1007\/s11894-014-0402-4 .","journal-title":"Curr Gastroenterol Rep"},{"key":"4146_CR67","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1136\/adc.87.2.93","volume":"2","author":"T Mushtaq","year":"2002","unstructured":"Mushtaq T, Ahmed SF. The impact of corticosteroids on growth and bone health. Arch Dis Child. 2002;2:93\u201396.","journal-title":"Arch Dis Child"},{"key":"4146_CR68","doi-asserted-by":"crossref","unstructured":"Gill JA, Goldsmith S, Kumar, A. Evaluating bone health in inflammatory bowel disease\u2014a single tertiary care Veterans Hospital experience. Indian J Gastroenterol 2015","DOI":"10.1007\/s12664-014-0528-1"},{"key":"4146_CR69","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1017\/S0029665114001621","volume":"74","author":"M O\u2019Sullivan","year":"2015","unstructured":"O\u2019Sullivan M. Vitamin D as a novel therapy in inflammatory bowel disease: new hope or false dawn? Proc Nutr Soc. 2015;74:5\u201312. doi: 10.1017\/S0029665114001621 .","journal-title":"Proc Nutr Soc"},{"key":"4146_CR70","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1002\/ibd.21601","volume":"17","author":"JP Etzel","year":"2011","unstructured":"Etzel JP, Larson MF, Anawalt BD, Collins J, Dominitz JA. Assessment and management of low bone density in inflammatory bowel disease and performance of professional society guidelines. Inflamm Bowel Dis. 2011;17:2122\u20132129. doi: 10.1002\/ibd.21601 .","journal-title":"Inflamm Bowel Dis"},{"key":"4146_CR71","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1111\/j.1572-0241.2006.00571.x","volume":"101","author":"A Kornbluth","year":"2006","unstructured":"Kornbluth A, Haynes M, Feldman S, et al. Do guidelines matter? Implementation of the ACG and AGA osteoporosis screening guidelines in inflammatory bowel disease (IBD) patients who meet the guidelines\u2019 criteria. Am J Gastroenterol. 2006;101:1546\u20131550.","journal-title":"Am J Gastroenterol"},{"key":"4146_CR72","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1053\/gast.2003.50107","volume":"124","author":"US National Library of Medicine National Institutes of Health","year":"2003","unstructured":"US National Library of Medicine National Institutes of Health. American Gastroenterological Association medical position statement: guidelines on osteoporosis in gastrointestinal diseases. Gastroenterology. 2003;124:791\u2013794.","journal-title":"Gastroenterology"},{"key":"4146_CR73","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0163-8343(96)00036-9","volume":"18","author":"EA Walker","year":"1996","unstructured":"Walker EA, Gelfand MD, Gelfand AN, Creed F, Katon WJ. The relationship of current psychiatric disorder to functional disability and distress in patients with inflammatory bowel disease. Gen Hosp Psychiatry. 1996;18:220\u2013229.","journal-title":"Gen Hosp Psychiatry"},{"key":"4146_CR74","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/00054725-200608000-00005","volume":"12","author":"E Fuller-Thomson","year":"2006","unstructured":"Fuller-Thomson E, Sulman J. Depression and inflammatory bowel disease: findings from two nationally representative Canadian surveys. Inflamm Bowel Dis. 2006;12:697\u2013707.","journal-title":"Inflamm Bowel Dis"},{"key":"4146_CR75","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1111\/j.1572-0241.2008.01980.x","volume":"103","author":"JR Walker","year":"2008","unstructured":"Walker JR, Ediger JP, Graff LA, et al. The Manitoba IBD cohort study: a population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders. Am J Gastroenterol. 2008;103:1989\u20131997. doi: 10.1111\/j.1572-0241.2008.01980.x .","journal-title":"Am J Gastroenterol"},{"key":"4146_CR76","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/MIB.0000000000000287","volume":"2","author":"E McDermott","year":"2015","unstructured":"McDermott E, Mullen G, Moloney J, et al. Body image dissatisfaction: clinical features, and psychosocial disability in inflammatory bowel disease. Inflamm Bowel Dis. 2015;2:353\u2013360. doi: 10.1097\/MIB.0000000000000287 .","journal-title":"Inflamm Bowel Dis"},{"key":"4146_CR77","first-page":"535","volume":"58","author":"K Nimalasuriya","year":"2009","unstructured":"Nimalasuriya K, Compton MT, Guillory VJ. Screening adults for depression in primary care: a position statement of the American College of Preventive Medicine. J Fam Pract. 2009;58:535\u2013538.","journal-title":"J Fam Pract"},{"key":"4146_CR78","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000200951","volume":"52","author":"G Moody","year":"1992","unstructured":"Moody G, Probert CS, Srivastava EM, Rhodes J, Mayberry JF. Sexual dysfunction amongst women with Crohn\u2019s disease: a hidden problem. Digestion. 1992;52:179\u2013183.","journal-title":"Digestion"},{"key":"4146_CR79","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.gtc.2011.03.003","volume":"40","author":"SM Moleski","year":"2011","unstructured":"Moleski SM, Choudhary C. Special considerations for women with IBD. Gastroenterol Clin North Am. 2011;40:387\u2013398. doi: 10.1016\/j.gtc.2011.03.003 .","journal-title":"Gastroenterol Clin North Am"},{"key":"4146_CR80","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1002\/ibd.20955","volume":"2","author":"ML Borum","year":"2010","unstructured":"Borum ML, Igiehon E, Shafa S. Physicians may inadequately address sexuality in women with inflammatory bowel disease. Inflamm Bowel Dis. 2010;2:1236\u20131243. doi: 10.1002\/ibd.20955 .","journal-title":"Inflamm Bowel Dis"},{"key":"4146_CR81","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/BF01541816","volume":"6","author":"JF Taylor","year":"1994","unstructured":"Taylor JF, Rosen RC, Leiblum SR. Self-report assessment of female sexual function: psychometric evaluation of the Brief Index of Sexual Functioning for Women. Arch Sex Behav. 1994;6:627\u2013643.","journal-title":"Arch Sex Behav"},{"key":"4146_CR82","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0090-4295(99)80304-5","volume":"46","author":"MP O\u2019Leary","year":"1995","unstructured":"O\u2019Leary MP, Fowler FJ, Lenderking WR, et al. A brief male sexual function inventory for urology. Urology. 1995;46:697\u2013706.","journal-title":"Urology"},{"key":"4146_CR83","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.thromres.2014.12.025","volume":"135","author":"WS Chung","year":"2015","unstructured":"Chung WS, Lin CL, Hsu WH, Kao CH. Inflammatory bowel disease increases the risks of deep vein thrombosis and pulmonary embolism in the hospitalized patients: a nationwide cohort study. Thromb Res. 2015;135:492\u2013496. doi: 10.1016\/j.thromres.2014.12.025 .","journal-title":"Thromb Res"},{"key":"4146_CR84","first-page":"127","volume":"3","author":"Faculty of Family Planning & Reproductive Health Care","year":"2003","unstructured":"Faculty of Family Planning & Reproductive Health Care, Clinical Effectiveness Unit. Contraceptive choices for women with inflammatory bowel disease. J Fam Plann Reprod Health Care. 2003;3:127\u2013135.","journal-title":"J Fam Plann Reprod Health Care"},{"key":"4146_CR85","volume-title":"Improving access to quality care in family planning. Medical eligibility criteria for contraceptive use","author":"World Health Organization (WHO)","year":"2000","unstructured":"World Health Organization (WHO). Improving access to quality care in family planning. Medical eligibility criteria for contraceptive use. 2nd ed. Geneva: World Health Organization; 2000.","edition":"2"},{"key":"4146_CR86","first-page":"356","volume":"14","author":"EA Petrelli","year":"1982","unstructured":"Petrelli EA, McKinley M, Troncale FJ. Ocular manifestations of inflammatory bowel disease. Ann Ophthalmol. 1982;14:356.","journal-title":"Ann Ophthalmol"},{"key":"4146_CR87","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1001\/archopht.1997.01100150063010","volume":"115","author":"JL Lyons","year":"1997","unstructured":"Lyons JL, Rosenbaum JT. Uveitis associated with inflammatory bowel disease compared with uveitis associated with spondyloarthropathy. Arch Ophthalmol. 1997;115:61\u201364.","journal-title":"Arch Ophthalmol"},{"key":"4146_CR88","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0002-9343(94)90131-7","volume":"96","author":"KG Saag","year":"1994","unstructured":"Saag KG, Koehnke R, Caldwell JR, et al. Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events. Am J Med. 1994;96:115.","journal-title":"Am J Med"},{"key":"4146_CR89","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3109\/00365521.2014.992041","volume":"50","author":"U Nieminen","year":"2015","unstructured":"Nieminen U, F\u00e4rkkil\u00e4 M. Malignancies in inflammatory bowel disease. Scand J Gastroenterol. 2015;50:81\u201389. doi: 10.3109\/00365521.2014.992041 .","journal-title":"Scand J Gastroenterol"},{"key":"4146_CR90","first-page":"CD000279","volume":"2","author":"PD Collins","year":"2006","unstructured":"Collins PD, Mpofu C, Watson AJ, Rhodes JM. Strategies for detecting colon cancer and\/or dysplasia in patients with inflammatory bowel disease. Cochrane Database Syst Rev. 2006;2:CD000279.","journal-title":"Cochrane Database Syst Rev"},{"key":"4146_CR91","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.gie.2013.10.026","volume":"79","author":"GG Konijeti","year":"2014","unstructured":"Konijeti GG, Shrime MG, Ananthakrishnan AN, Chan AT. Cost-effectiveness analysis of chromoendoscopy for colorectal cancer surveillance in patients with ulcerative colitis. Gastrointest Endosc. 2014;79:455\u2013465. doi: 10.1016\/j.gie.2013.10.026 .","journal-title":"Gastrointest Endosc"},{"key":"4146_CR92","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1053\/j.gastro.2015.01.031","volume":"2015","author":"L Laine","year":"2015","unstructured":"Laine L, Kaltenbach T, Barkun A, et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastroenterology. 2015;2015:639\u2013651. doi: 10.1053\/j.gastro.2015.01.031 .","journal-title":"Gastroenterology"},{"key":"4146_CR93","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.gie.2014.10.030","volume":"81","author":"AK Shergill","year":"2015","unstructured":"Shergill AK, Lightdale JR, Bruining DH, et al. The role of endoscopy in inflammatory bowel disease. Gastrointest Endosc. 2015;81:1101\u20131121. doi: 10.1016\/j.gie.2014.10.030 .","journal-title":"Gastrointest Endosc"},{"key":"4146_CR94","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/ajg.2009.727","volume":"105","author":"A Kornbluth","year":"2010","unstructured":"Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults: American college of gastroenterology, practice parameters committee. Am J Gastroenterol. 2010;105:501\u2013523. doi: 10.1038\/ajg.2009.727 .","journal-title":"Am J Gastroenterol"},{"key":"4146_CR95","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1053\/j.gastro.2009.12.037","volume":"138","author":"FA Farraye","year":"2010","unstructured":"Farraye FA, Odze RD, Eaden J, et al. AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010;138:738\u2013745.","journal-title":"Gastroenterology"},{"key":"4146_CR96","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/ajg.2013.249","volume":"108","author":"T Jess","year":"2013","unstructured":"Jess T, Horv\u00e1th-Puh\u00f3 E, Fallingborg J, Rasmussen HH, Jacobsen BA. Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: a Danish population-based cohort study. Am J Gastroenterol. 2013;108:1869\u20131876. doi: 10.1038\/ajg.2013.249 .","journal-title":"Am J Gastroenterol"},{"key":"4146_CR97","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cgh.2014.07.036","volume":"13","author":"C Rungoe","year":"2015","unstructured":"Rungoe C, Simonsen J, Riis L, Frisch M, Langholz E, Jess T. Inflammatory bowel disease and cervical neoplasia: a population-based nationwide cohort study. Clin Gastroenterol Hepatol. 2015;13:693\u2013700. doi: 10.1016\/j.cgh.2014.07.036 .","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4146_CR98","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1572-0241.2007.01582.x","volume":"103","author":"S Kane","year":"2008","unstructured":"Kane S, Khatibi B, Reddy D. Higher incidence of abnormal Pap smears in women with inflammatory bowel disease. Am J Gastroenterol. 2008;103:631\u2013636.","journal-title":"Am J Gastroenterol"},{"key":"4146_CR99","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1097\/AOG.0b013e3181c6f8a4","volume":"114","author":"ACOG Practice Bulletin no","year":"2009","unstructured":"ACOG Practice Bulletin no. 109 Cervical cytology screening. Obstet Gynecol. 2009;114:1409\u20131420. doi: 10.1097\/AOG.0b013e3181c6f8a4 .","journal-title":"Obstet Gynecol"},{"key":"4146_CR100","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/sj.bjc.6600350","volume":"87","author":"T Bjorge","year":"2002","unstructured":"Bjorge T, Engeland A, Luostarinen T, et al. Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study. Br J Cancer. 2002;87:61\u201364.","journal-title":"Br J Cancer"},{"key":"4146_CR101","first-page":"1014","volume":"51","author":"JM Palefsky","year":"1991","unstructured":"Palefsky JM, Holly EA, Gonzales J, Berline J, Ahn DK, Greenspan JS. Detection of human papillomavirus DNA in anal intraepithelial neoplasia and anal cancer. Cancer Res. 1991;51:1014\u20131019.","journal-title":"Cancer Res"},{"key":"4146_CR102","first-page":"1345","volume":"140","author":"SR Zaki","year":"1992","unstructured":"Zaki SR, Judd R, Coffield LM, Greer P, Rolsston F, Evatt BL. Human papillomavirus infection and anal carcinoma. Retrospective analysis by in situ hybridization and the polymerase chain reaction. Am J Pathol. 1992;140:1345\u20131355.","journal-title":"Am J Pathol"},{"key":"4146_CR103","unstructured":"New York State AIDS Malignancy Consortium. Criteria for the medical care of adults with HIV infection. New York State Department of Health AIDS Institute 2004; pp. 1\u201318."},{"key":"4146_CR104","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1053\/j.gastro.2012.05.004","volume":"143","author":"MD Long","year":"2012","unstructured":"Long MD, Martin CF, Pipkin CA, Herfarth HH, Sandler RS, Kappelman MD. Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease. Gastroenterology. 2012;143:390\u2013399. doi: 10.1053\/j.gastro.2012.05.004 .","journal-title":"Gastroenterology"},{"key":"4146_CR105","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.cgh.2013.04.033","volume":"12","author":"S Singh","year":"2014","unstructured":"Singh S, Nagpal SJ, Mujrad MH, et al. Inflammatory bowel disease is associated with an increased risk of melanoma: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2014;12:210\u2013218. doi: 10.1016\/j.cgh.2013.04.033 .","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4146_CR106","doi-asserted-by":"publisher","first-page":"267","DOI":"10.15403\/jgld.2014.1121.233.mrmk","volume":"23","author":"MR McKenna","year":"2014","unstructured":"McKenna MR, Stobaugh DJ, Deepak P. Melanoma and non-melanoma skin cancer in inflammatory bowel disease patients following tumor necrosis factor-alpha inhibitor monotherapy and in combination with thiopurines: analysis of the Food and Drug Administration Adverse Event Reporting System. J Gastrointest Liver Dis. 2014;23:267\u2013271. doi: 10.15403\/jgld.2014.1121.233.mrmk .","journal-title":"J Gastrointest Liver Dis"},{"key":"4146_CR107","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/art.1780370304","volume":"37","author":"JM Kremer","year":"1994","unstructured":"Kremer JM, Alarc\u00f3n GS, Lightfoot RW, et al. Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology. Arthritis Rheum. 1994;37:316\u2013328.","journal-title":"Arthritis Rheum"},{"key":"4146_CR108","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","volume":"149","author":"M Pai","year":"2008","unstructured":"Pai M, Zwerling A, Menziers D. Systematic review: T-cell based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med. 2008;149:177\u2013184.","journal-title":"Ann Intern Med"},{"key":"4146_CR109","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1097\/MIB.0000000000000147","volume":"20","author":"SH Wong","year":"2014","unstructured":"Wong SH, Ip M, Tang W, et al. Performance of interferon-gamma release assay for tuberculosis screening in inflammatory bowel disease patients. Inflamm Bowel Dis. 2014;20:2067\u20132072. doi: 10.1097\/MIB.0000000000000147 .","journal-title":"Inflamm Bowel Dis"},{"key":"4146_CR110","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1056\/NEJMoa043335","volume":"353","author":"WJ Sandborn","year":"2005","unstructured":"Sandborn WJ, Colombel JF, Enns R, et al. Natalizumab induction and maintenance therapy for Crohn\u2019s disease. N Engl J Med. 2005;353:1912\u20131925.","journal-title":"N Engl J Med"},{"key":"4146_CR111","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1056\/NEJMoa051782","volume":"353","author":"BK Kleinschmidt-demasters","year":"2005","unstructured":"Kleinschmidt-demasters BK, Tyler KL. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N Engl J Med. 2005;353:369\u2013374.","journal-title":"N Engl J Med"},{"key":"4146_CR112","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1056\/NEJMoa051847","volume":"353","author":"A Langer-Gould","year":"2005","unstructured":"Langer-Gould A, Atlas SW, Green AJ, Bollen AW, Pelletier D. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med. 2005;353:375\u2013381.","journal-title":"N Engl J Med"},{"key":"4146_CR113","unstructured":"Food and Drug Administration. Information on natalizumab (marketed as Tysabri). Food and Drug Administration, 2009.11.18, cited 2015.6.1 2009. http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm107198.htm ."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-016-4146-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-016-4146-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-016-4146-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T11:26:40Z","timestamp":1567769200000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-016-4146-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,9]]},"references-count":113,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["4146"],"URL":"https:\/\/doi.org\/10.1007\/s10620-016-4146-x","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,9]]}}}